| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10934 | 2021 |
| A mass spectrometric-derived cell surface protein atlas D Bausch-Fluck, A Hofmann, T Bock, AP Frei, F Cerciello, A Jacobs, ... PloS one 10 (4), e0121314, 2015 | 426 | 2015 |
| Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ... The Lancet 372 (9648), 1484-1492, 2008 | 402 | 2008 |
| Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report … L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ... Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010 | 400 | 2010 |
| Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance L Bonapace, BC Bornhauser, M Schmitz, G Cario, U Ziegler, FK Niggli, ... The Journal of clinical investigation 120 (4), 1310-1323, 2010 | 389 | 2010 |
| Transcriptional repression by RING finger protein TIF1β that interacts with the KRAB repressor domain of KOX1 P Moosmann, O Georgiev, B Le Douarin, JP Bourquin, W Schaffner Nucleic acids research 24 (24), 4859-4867, 1996 | 339 | 1996 |
| Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98 C Von Neuhoff, D Reinhardt, A Sander, M Zimmermann, J Bradtke, ... Journal of clinical oncology 28 (16), 2682-2689, 2010 | 298 | 2010 |
| IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia M Stanulla, E Dagdan, M Zaliova, A Möricke, C Palmi, G Cazzaniga, ... Journal of Clinical Oncology 36 (12), 1240-1249, 2018 | 275 | 2018 |
| Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options U Fischer, M Forster, A Rinaldi, T Risch, S Sungalee, HJ Warnatz, ... Nature genetics 47 (9), 1020-1029, 2015 | 256 | 2015 |
| SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements O Nayler, W Strätling, JP Bourquin, I Stagljar, L Lindemann, H Jasper, ... Nucleic acids research 26 (15), 3542-3549, 1998 | 242 | 1998 |
| An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome CJ Harrison, AV Moorman, C Schwab, AJ Carroll, EA Raetz, M Devidas, ... Leukemia 28 (5), 1015-1021, 2014 | 234 | 2014 |
| Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 U Creutzig, M Zimmermann, JP Bourquin, MN Dworzak, G Fleischhack, ... Blood, The Journal of the American Society of Hematology 122 (1), 37-43, 2013 | 230 | 2013 |
| Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia V Frismantas, MP Dobay, A Rinaldi, J Tchinda, SH Dunn, J Kunz, ... Blood, The Journal of the American Society of Hematology 129 (11), e26-e37, 2017 | 226 | 2017 |
| Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment O Hrusak, T Kalina, J Wolf, A Balduzzi, M Provenzi, C Rizzari, S Rives, ... European Journal of Cancer 132, 11-16, 2020 | 225 | 2020 |
| Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or-7 S McComb, PK Chan, A Guinot, H Hartmannsdottir, S Jenni, MP Dobay, ... Science advances 5 (7), eaau9433, 2019 | 225 | 2019 |
| Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 M Rasche, M Zimmermann, L Borschel, JP Bourquin, M Dworzak, ... Leukemia 32 (10), 2167-2177, 2018 | 225 | 2018 |
| Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling JP Bourquin, A Subramanian, C Langebrake, D Reinhardt, O Bernard, ... Proceedings of the National Academy of Sciences 103 (9), 3339-3344, 2006 | 219 | 2006 |
| Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia D Bhojwani, R Sposto, NN Shah, V Rodriguez, C Yuan, ... Leukemia 33 (4), 884-892, 2019 | 213 | 2019 |
| IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol P Dörge, B Meissner, M Zimmermann, A Möricke, A Schrauder, ... Haematologica 98 (3), 428, 2013 | 199 | 2013 |
| Activating mutations in human acute megakaryoblastic leukemia S Malinge, C Ragu, V Della-Valle, D Pisani, SN Constantinescu, C Perez, ... Blood, The Journal of the American Society of Hematology 112 (10), 4220-4226, 2008 | 169 | 2008 |
